Last reviewed · How we verify
NCT04756635: Performance
Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity
NA trial testing Experimental Group in Healthy Males in 50 participants. Status unknown.
12 April 2021
Quick facts
| Lead sponsor | Faculdade de Motricidade Humana |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 22 May 2018 |
| Primary completion | 12 April 2021 |
| Estimated completion | 5 February 2023 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Experimental Group
Conditions studied
- Healthy Males — all drugs for Healthy Males →
- Men — all drugs for Men →
Sponsor
Faculdade de Motricidade Humana
Who can join
Adults 18 to 30, male only, with Healthy Males or Men. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The therapeutic use of caloric restriction and intermittent fasting (IF) protocols improves life span and health related quality of life. The effects of fasting protocols on athletic performance and training adaptations have been primarily studied in athletes undergoing the Ramadan IF protocol or in athletes willing to decrease body fat, while maintaining or increasing lean body mass. Data from these studies are somewhat conflicting and unclear. Moreover, the effects of IF on muscular strength, as well as in aerobic and anaerobic capacity remain largely unknown. Anecdotal evidence from experienced participants in strength, power and endurance training or sports, indicates an increased ability to acutely display higher levels of work capacity in the fasted vs. fed state. The goal of this project is to determine the effects of 4 wks of IF on neuromuscular performance, aerobic and anaerobic capacity of well-trained young adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of time-restricted feeding on supramaximal exercise performance and body composition: a randomized and counterbalanced crossover study in healthy men
Correia JM, Santos I, Pezarat-Correia P, Minderico C, et al · · 2021 · DOI 10.21203/rs.3.rs-612812/v1
Verify or expand the search:
- PubMed search for NCT04756635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental Group
Trials testing the same drug.
- NCT07511894 — Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer · Phase 2 · not yet recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
- NCT07316946 — Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial · NA · not yet recruiting
- NCT07125820 — A Dual Intervention in Migraine Treatment: Tens and Exercise · NA · not yet recruiting
- NCT07514637 — Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.I · Phase 2 · recruiting
Other Faculdade de Motricidade Humana trials
Trials by the same sponsor.
- NCT07079722 — More Health Less Diabetes · NA · recruiting
- NCT06919237 — Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardior · NA · not yet recruiting
- NCT05090501 — The Effects of High Intensity Circuit Training in Nature Vs. Indoor on Exercise Performance, and Wellbeing · NA · completed
- NCT07105410 — Hypoalgesic Effects of Exercise and Training of Different Modalities · NA · completed
- NCT05380089 — Effects of Hydration Changes on Neuromuscular Function of Athletes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04756635 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Faculdade de Motricidade Humana
- Last refreshed: 26 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04756635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing